CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes EVP & General Counsel gave up 2,781 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 11,296 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and Chief Medical Officer gave up 17,435 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 38,540 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Commercial Officer gave up 31,592 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Agreement ended · Unregistered share sale · Regulation FD disclosure
- 144 Insider Sale of Securities
- 4 Planned sale EVP & Chief Commercial Officer sold 17,600 shares at an average $48.17 ($847,855)
- 4 Open-market sale Director sold 3,650 shares at $47.03 ($171,673)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes President and CEO gave up 8,983 shares (to pay taxes)
- 4 Open-market sale Director sold 34,853 shares at $47.21 ($1,645,536)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 4 Planned sale EVP & Chief Financial Officer sold 30,000 shares at an average $40.53 ($1,215,753)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
Page 4 of 44 · 872 filings